Top Ten Tips Palliative Care Clinicians Should Know About Sickle Cell Disease

Sickle cell disease (SCD) is a congenital, life-limiting illness that affects millions worldwide. It carries a high symptom burden and decreased quality of life. Although disease-modifying and even potentially curative therapies have recently emerged, significant tradeoffs and inequitable access remain. Opioids are the mainstay for acute pain but do not adequately address chronic pain syndromes that many people with SCD face. Additionally, individuals with SCD encounter emotional and psychosocial challenges, compounded by biases and structural racism within and outside the health care system. Despite improved life expectancy, prognostication is difficult as death can follow unpredictable and catastrophic complications; and older individuals develop other chronic illnesses associated with shortened survival, underscoring a role for advance care planning. Historically, palliative care (PC) involvement in SCD has been limited. This article, created by a multidisciplinary group of clinicians, offers an overview of SCD to better empower PC clinicians caring for individuals with SCD.

Authors

Institutions

Publication Details

Journal
Journal of Palliative Medicine
Published
2026-07-26
DOI
https://doi.org/10.1177/10966218261473333
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Top Ten Tips Palliative Care Clinicians Should Know About Sickle Cell Disease

CM Jones, Eberechi Nwogu-Onyemkpa, Adrienne D. Mishkin, Dana Guyer et al.
Journal of Palliative Medicine
Hemoglobinopathies and Related Disorders
article

Top Ten Tips Palliative Care Clinicians Should Know About Sickle Cell Disease

CM Jones, Eberechi Nwogu-Onyemkpa, Adrienne D. Mishkin, Dana Guyer, Jesse A. Soodalter, Craig D. Blinderman, Marsha Treadwell, AC Allen, S. Lanzkron, Samuel R. Wilson, Rushil V. Patel, C. Patrick Carroll
article en

Abstract

Sickle cell disease (SCD) is a congenital, life-limiting illness that affects millions worldwide. It carries a high symptom burden and decreased quality of life. Although disease-modifying and even potentially curative therapies have recently emerged, significant tradeoffs and inequitable access remain. Opioids are the mainstay for acute pain but do not adequately address chronic pain syndromes that many people with SCD face. Additionally, individuals with SCD encounter emotional and psychosocial challenges, compounded by biases and structural racism within and outside the health care system. Despite improved life expectancy, prognostication is difficult as death can follow unpredictable and catastrophic complications; and older individuals develop other chronic illnesses associated with shortened survival, underscoring a role for advance care planning. Historically, palliative care (PC) involvement in SCD has been limited. This article, created by a multidisciplinary group of clinicians, offers an overview of SCD to better empower PC clinicians caring for individuals with SCD.

Journal of Palliative Medicine
University of North Carolina at Chapel Hill (US), Sutter Health (US), Memorial Sloan Kettering Cancer Center (US), Johns Hopkins University (US), Thomas Jefferson University (US), Duke University (US), University of California, San Francisco (US), Washington University in St. Louis (US), Brown University (US), Columbia University Irving Medical Center (US), Johns Hopkins Medicine (US), University of Alabama at Birmingham (US)
Openalex Percentile: Top 9%
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.